The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Osadchuk M.A.

I.M. Sechenov First Moscow State Medical University

Vasilieva I.N.

Sechenov University

Kozlov V.V.

Interdistrict Petrogradsko-Primorsky TB Dispensary No. 3

Mitrokhina O.I.

Sechenov University

Metabolic syndrome as a risk factor for oncogenesis

Authors:

Osadchuk M.A., Vasilieva I.N., Kozlov V.V., Mitrokhina O.I.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2023;26(1): 70‑79

DOI: 10.17116/profmed20232601170

Read: 4232 times

Download PDF (RU)
Contact the author
Table of contents

METABOLIC SYNDROME AS A RISK FACTOR FOR ONCOGENESIS
METABOLIC SYNDROME AS A RISK FACTOR FOR ONCOGENESIS

To cite this article:

Osadchuk MA, Vasilieva IN, Kozlov VV, Mitrokhina OI. Metabolic syndrome as a risk factor for oncogenesis. Russian Journal of Preventive Medicine. 2023;26(1):70‑79. (In Russ.)
https://doi.org/10.17116/profmed20232601170

 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Inte­rnational multicenter randomized double-blind placebo-controlled study asse­ssing the effi­cacy and safety of sequential therapy with Mexi­dol and Mexi­dol FORTE 250 in patients with chro­nic brain ischemia (MEMO): suba­nalysis in patients with arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2024;(10):72-83
Reso­lution of the expert council «Possibilities of neuroprotective therapy in patients with arte­rial hype­rtension and cognitive diso­rders». Russian Journal of Preventive Medi­cine. 2024;(11):85-93
The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medi­cine. 2024;(11):141-146
Perfection of cancer patients routing model at the medi­cal care different stages. Russian Journal of Preventive Medi­cine. 2024;(12):7-15
Predictors of Enga­gement and Active participation of Patients with Unco­ntrolled Hype­rtension in the Tele­health Surveillance Program. Russian Journal of Preventive Medi­cine. 2024;(12):37-43
Problems of regu­lar medi­cal check-up orga­nization of young males aged 15—17 years with cardiometabolic diseases. Russian Journal of Preventive Medi­cine. 2024;(12):81-87
Reco­gnan (citicoline) prescribing in cere­brovascular diseases and type 2 diabetes mellitus patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):23-27
The possibilities of Mexi­dol in the complex therapy of arte­rial hype­rtension. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):572-580
Immu­nology of the cervix in normal and pathological conditions (literature review). Russian Journal of Human Reproduction. 2024;(5):108-117
Meta­bolic syndrome and anti­psychotic therapy of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):165-170
Abstract:

Metabolic syndrome (MS) is a risk factor for cardiovascular diseases and cancer, although the complete relationship between MS and cancer remains a problem far from being resolved. Hormonal and inflammatory changes in adipose tissue were reported to be associated with cancer.

OBJECTIVE

To study the probability of cancer development in patients with MS.

MATERIAL AND METHODS

An observational retrospective study including 994 patients (289 males and 705 females) was carried out at the outpatient center of Moscow (Diagnostic Center No. 5 of the Moscow Healthcare Department). The mean age of study patients was 62.48±13.49 years (20 to 87 years). The incidence of cancer and oncogenesis factors in patients with MS over 10 years and the association between its components (abdominal obesity, arterial hypertension, hyperglycemia, and hypertriglyceridemia) were analyzed. Odds ratios of carcinogenesis and 95% confidence intervals were estimated using the cross tables method.

RESULTS

Cancer onset was observed in every fifth patient with an MS duration of 13.5±2.41 years. Abdominal obesity was associated with an increased risk of various cancers. The most significant risk was associated with grade I obesity, metabolic disorders, and the age of patients. In addition, a retrospective analysis of data from MS patients revealed a protective effect of oral antidiabetic and hypolipidemic agents on cancer risk and mortality, although the mechanisms are not fully understood.

CONCLUSIONS

Metabolic syndrome is a risk factor for cardiovascular diseases and cancer. Cardiovascular diseases, particularly arterial hypertension, increase the risk of cancer several-fold. Hyperglycemia also increases the risk of malignant neoplasms. Dyslipidemia has no effect on cancer development; however, more detailed studies with a larger sample are needed.

Keywords:

metabolic syndrome
cancer
arterial hypertension
diabetes mellitus
dyslipidemia

Authors:

Osadchuk M.A.

I.M. Sechenov First Moscow State Medical University

Vasilieva I.N.

Sechenov University

Kozlov V.V.

Interdistrict Petrogradsko-Primorsky TB Dispensary No. 3

Mitrokhina O.I.

Sechenov University

Received:

08.06.2022

Accepted:

04.10.2022

Close metadata

References:

  1. WHO (2020) Obesity and Owerweight. Accessed December 15, 2022. https://www.who.int/news-room/fact-sheets/detail/obesity-and-owerweight
  2. Castro-Barquero S, Ruiz-León AM, Sierra-Pérez M, Estruch R, Casas R. Dietary Strategies for Metabolic Syndrome: A Comprehensive Review. Nutrients. 2020;12(10):2983. https://doi.org/10.3390/nu12102983
  3. Chen YY, Fang WH, Wang CC, Kao TW, Chang YW, Yang HF, Wu CJ, Sun YS, Chen WL. Association of Percentage Body Fat and Metabolic Health in Offspring of Patients with Cardiovascular Diseases. Scientific Reports. 2018; 8(1):13831. https://doi.org/10.1038/s41598-018-32230-7
  4. Litwin M, Kułaga Z. Obesity, metabolic syndrome, and primary hypertension. Pediatric Nephrology. 2021;36:825-837.  https://doi.org/10.1007/s00467-020-04579-3
  5. Salukhov VV, Kadin DV. Obesity as a cancer risk factor. Literature review. Medicinskii sovet. 2019;4:94-102. (In Russ.). https://doi.org/10.21518/2079-701X-2019-4-94-102
  6. Wambui G. Gathirua-Mwangi, Patrick O. Monahan, Mwangi J. Murage, Jianjun Zhang. Metabolic Syndrome and Total Cancer Mortality in the Third National Health and Nutrition Examination Survey. Cancer Causes and Control. 2017;28(2):127-136.  https://doi.org/10.1007/s10552-016-0843-1
  7. Jaacks LM, Vandevijvere S, Pan A, McGowan CJ, Wallace C, Imamura F, Mozaffarian D, Swinburn B, Ezzati M. The Obesity Transition: Stages of the global epidemic. Lancet. Diabetes and Endocrinology. 2019;7(3):231-240.  https://doi.org/10.1016/S2213-8587(19)30026-9
  8. Oganov RG, Mamedov MN. Nacional’nye klinicheskie rekomendacii. Vserossijskoe nauchnoe obshchestvo kardiologov. Cbornik statej. M.: OOO «Siliceya-Poligraf»; 2009. (In Russ.).
  9. Prevention of type 2 diabetes mellitus: the role and place of metformin. Draft clinical recommendations. Endokrinologiya: novosti, mneniya, obuchenie. Preprintnoe izdanie. 2017;1:1-9. Accessed December 15, 2022. (In Russ.). https://www.endocrincentr.ru/sites/default/files/all/PRESS/07.04.17/Project_02.03.17.pdf
  10. Hopkins BD, Goncalves MD, Cantley LC. Cantley. Obesity and Cancer Mechanisms: Cancer Metabolism. Journal of Clinical Oncology. 2016;34(35): 4277-4283. https://doi.org/10.1200/JCO.2016.67.9712
  11. Zhang AMY, Wellberg EA, Kopp JL, Johnson JD. Hyperinsulinemia in Obesity, Inflammation, and Cancer. Diabetes and Metabolism Journal. 2021;45(3): 285-311.  https://doi.org/10.4093/dmj.2020.0250
  12. Clifton KK, Ma CX, Fontana L, Peterson LL. Intermittent fasting in the prevention and treatment of cancer. CA: A Cancer Journal for Clinicians. 2021;71(6):527-546.  https://doi.org/10.3322/caac.21694
  13. Kaprin AD, Matskeplishvili ST, Potievskaya VI, Popovkina OE, Bolotina LV, Shklyaeva AV, Poluektova MV. Cardiovascular diseases in cancer patients. Onkologiya. Zhurnal im. P.A. Gercena. 2019;8(2):139-147. (In Russ.). https://doi.org/10.17116/onkolog20198021139
  14. Aparecida Silveira E, Vaseghi G, de Carvalho Santos AS, Kliemann N, Masoudkabir F, Noll M, Mohammadifard N, Sarrafzadegan N, de Oliveira C. Visceral Obesity and Its Shared Role in Cancer and Cardiovascular Disease: A Scoping Review of the Pathophysiology and Pharmacological Treatments. International Journal of Molecular Sciences. 2020;21(23):9042. https://doi.org/10.3390/ijms21239042
  15. de Boer RA, Aboumsallem JP, Bracun V, Leedy D, Cheng R, Patel S, Rayan D, Zaharova S, Rymer J, Kwan JM, Levenson J, Ronco C, Thavendiranathan P, Brown SA. A new classification of cardio-oncology syndromes. Cardio-Oncology. 2021;7(1):24.  https://doi.org/10.1186/s40959-021-00110-1
  16. Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, de Jong S, Haubner BJ, Nagengast WB, Lyon AR, van der Vegt B, van Veldhuisen DJ, Westenbrink BD, van der Meer P, Silljé HHW, de Boer RA. Heart failure stimulates tumor growth by circulating factors. Blood Circulation. 2018; 138(7):678-691.  https://doi.org/10.1161/CIRCULATIONAHA.117.030816
  17. Han H, Guo W, Shi W, Yu Y, Zhang Y, Ye X, He J. Hypertension and breast cancer risk: a systematic review and meta-analysis. Scientific Reports. 2017; 7(1):44877. https://doi.org/10.1038/srep44877
  18. van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, Mathijssen RHJ, Danser AHJ, Lang NN. Lang. Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients. Circulation Research. 2021;128(7):1040-1061. https://doi.org/10.1161/CIRCRESAHA.121.318051
  19. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-444.  https://doi.org/10.1038/nature07205
  20. Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Current Opinion in Pharmacology. 2016;29:77-89.  https://doi.org/10.1016/j.coph.2016.07.005
  21. Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Dannenberg, and Clifford A. Hudis. Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammtion. Journal of Clinical Oncology. 2016;34(35):4270-4276. https://doi.org/10.1200/JCO.2016.67.4283
  22. Glenny EM, Coleman MF, Giles ED, Wellberg EA, Hursting SD. Designing Relevant Preclinical Rodent Models for Studying Links Between Nutrition, Obesity, Metabolism, and Cancer. Annual Review of Nutrition. 2021; 41:253-282.  https://doi.org/10.1146/annurev-nutr-120420-032437
  23. Carter P, Vithayathil M, Kar S, Potluri R, Mason AM, Larsson SC, Burgess S. Predicting the effect of statins on cancer risk using genetic variants from a Mendelian randomization study in the UK Biobank. eLife. 2020;9:e57191. https://doi.org/10.7554/eLife.57191
  24. Davenport L. Statins and Lower Cancer Mortality; Risk Cut by Up to a Half. Medscape. June 10, 2015. https://www.medscape.com/viewarticle/846189
  25. Fernandez CJ, George AS, Subrahmanyan NA, Pappachan JM. Epidemiological link between obesity, type 2 diabetes mellitus and cancer. World Journal of Methodology. 2021;11(3):23-45.  https://doi.org/10.5662/wjm.v11.i3.23
  26. Cohen DH, LeRoith D. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocrine-Related Cancer. 2012;19(5): 27-45.  https://doi.org/10.1530/ERC-11-0374
  27. Wang M, Yang Y, Liao Z. Diabetes and cancer: Epidemiological and biological links. World Journal of Diabetes. 2020;11(6):227-238.  https://doi.org/10.4239/wjd.v11.i6.227
  28. Supabphol S, Seubwai W, Wongkham S, Saengboonmee C. High glucose: an emerging association between diabetes mellitus and cancer progression. Journal of Molecular Medicine. 2021;99(9):1175-1193. https://doi.org/10.1007/s00109-021-02096-w
  29. Talib WH, Mahmod AI, Abuarab SF, Hasen E, Munaim AA, Haif SK, Ayyash AM, Khater S, Al-Yasari IH, Kury LTA. Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products. Molecules. 2021;26(8):2179. https://doi.org/10.3390/molecules26082179
  30. Kim MS, Lee DY. Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus. Annals of Pediatric Endocrinology and Metabolism. 2015;20(2):69-73.  https://doi.org/10.6065/apem.2015.20.2.69
  31. Chen YC, Li H, Wang J. Mechanisms of metformin inhibiting cancer invasion and migration. American Journal of Translational Research. 2020;12(9): 4885-4901 Accessed May, 30, 2022. https://pubmed.ncbi.nlm.nih.gov/33042396/
  32. Zlokachestvennye novoobrazovaniya v Rossii v 2020 godu (zabolevaemost’ i smertnost’). Pod red. Kaprina A.D., Starinskogo V.V., Shahzadovoj A.O. M.: MNIOI im. P.A. Gercena — filial FGBU «NMIC radiologii» Minzdrava Rossii; 2021. Accessed December 15, 2022. (In Russ.). https://glavonco.ru/cancer_register/%D0%97%D0%B0%D0%B1%D0%BE%D0%BB_2020_%D0%AD%D0%BB%D0%B5%D0%BA%D1%82%D1%80.pdf
  33. Edward J. Evans, James DeGregori. Cells with cancer‐associated mutations overtake our tissues as we age. Aging and Cancer. 2021;2(3):82.  https://doi.org/10.1002/aac2.12037
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.